The American Lung Association featured Ruogang Zhao in an article about pulmonary fibrosis researchers, noting that Zhao and his team developed an experimental model to show how macrophages contribute to the progression of lung fibrosis.
RegMedNet reported Ruongang Zhao has received a $3 million grant from the National Institutes of Health to study a promising type of immunotherapy treatment for solid tumors.